Management of Intractable Vomiting in Sickle Cell Anemia

Initial Assessment and Management

Intractable vomiting in sickle cell anemia patients should be managed with a stepwise approach using dopamine receptor antagonists as first-line therapy, followed by 5-HT3 antagonists and corticosteroids if needed, while ensuring adequate hydration and investigating underlying causes, as recommended by the National Comprehensive Cancer Network 1
Rule out common causes of vomiting in sickle cell patients, including medication-induced nausea, severe constipation or fecal impaction, gastroparesis, central nervous system involvement, and gastric outlet obstruction from intra-abdominal pathology, according to the National Comprehensive Cancer Network 1
Ensure aggressive hydration, as sickle cell patients dehydrate easily due to impaired urinary concentrating ability, with oral hydration preferred when possible, as suggested by Praxis Medical Insights 2

Initiate treatment with dopamine receptor antagonists, such as haloperidol, metoclopramide, prochlorperazine, and olanzapine, as recommended by the National Comprehensive Cancer Network 1
Add a 5-HT3 antagonist, such as ondansetron, if vomiting persists, according to the National Comprehensive Cancer Network 1
Consider adding an anticholinergic agent, antihistamine, or lorazepam if anxiety contributes to nausea/vomiting, as suggested by the National Comprehensive Cancer Network 1
Add a corticosteroid, such as dexamethasone, if vomiting still persists, according to the National Comprehensive Cancer Network 1

Monitor oxygen saturation and administer oxygen to keep SpO2 above baseline or 96% (whichever is higher), as recommended by Praxis Medical Insights 2
Maintain normothermia as hypothermia can lead to shivering and peripheral stasis, which increases sickling, according to Praxis Medical Insights 2, 3
Obtain blood cultures if fever is present and initiate antibiotics if temperature reaches ≥38.0°C or if there are signs of sepsis, as suggested by Praxis Medical Insights 4

Regular pain assessment using validated pain scales, as recommended by Praxis Medical Insights 2
Continuous oxygen monitoring until saturation is maintained at baseline in room air, according to Praxis Medical Insights 2
Consider early mobilization when appropriate to prevent complications like deep vein thrombosis, as suggested by Praxis Medical Insights 3
Low threshold for admission to high dependency or intensive care units for patients with severe symptoms or complications, according to Praxis Medical Insights 2

Consider non-pharmacologic therapies such as acupuncture, hypnosis, and cognitive behavioral therapy, as recommended by the National Comprehensive Cancer Network 1
Ensure regular assessment by hematology specialists, as suggested by Praxis Medical Insights 2

Overlooking the possibility of acute chest syndrome, which can be precipitated by infection and may present with gastrointestinal symptoms, as noted by Praxis Medical Insights 4
Neglecting thromboprophylaxis in immobilized patients, as sickle cell patients have an increased risk of thrombosis, according to Praxis Medical Insights 3